Navigation Links
LABSCO Hires George Willett as New Vice President and Chief Financial Officer
Date:8/29/2011

LOUISVILLE, Ky., Aug. 29, 2011 /PRNewswire/ -- Laboratory Supply Company (LABSCO), the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States, continues to expand its executive leadership team with the new appointment of George Willett as vice president and chief financial officer.

Willett's career has included over 17 years serving as chief financial officer for several leading companies.  He comes to LABSCO from Summit Energy, Louisville, Ky., where he supported the successful completion of two acquisitions and the subsequent sale of the company.  Previous to Summit, Willett was chief financial officer at National Processing Company and High Speed Access Corporation, both of Louisville, Ky., American Pathology Associates, Nashville, Tenn., and Regent Communications, Inc., Cincinnati, Ohio.  Willett started his finance career as an auditor for Coopers & Lybrand and corporate accounting officer at the United States Shoe Corporation, both of Cincinnati, Ohio.  Willett is a graduate of Cincinnati's Xavier University.

"George brings a wealth of valuable financial knowledge, management and experience to our executive team, and we are honored he is joining us," Steve Nielsen, LABSCO's chairman and chief executive officer, said.  "We look forward to his contributions to corporate finance, strategy development and execution as we work to provide an industry leading service experience to our customers and suppliers."

LABSCO also announced key additions to its sales management team with the hiring of Dwight Bowlin as branch sales manager for Lafayette, La., and surrounding service areas, and the promotion of Dean Schumacher to sales manager for the Lees Summit, Mo./Des Moines, Iowa, region.  Prior to LABSCO, Bowlin worked for Siemens Healthcare Diagnostics as national distribution relations manager.  Bowlin has more than 30 years of biomedical, clinical laboratory and medical product sales experience with many healthcare companies.  Schumacher is an experienced associate who has made valuable contributions to LABSCO's sales efforts.

"We are excited to add Dwight and Dean to our growing sales management team.  We are committed to building an industry-leading sales organization and our customers will clearly benefit from their extensive experience in sales and knowledge of laboratory products and distribution," said Joel Weihe, LABSCO's vice president of sales and marketing.

About LABSCO

Laboratory Supply Company was founded by Charles (Charlie) Davis in Louisville, Kentucky in 1972.  LABSCO has nine distribution centers and has grown to be the largest privately held distributor of clinical laboratory products in the United States.  LABSCO is known for its expertise in the clinical laboratory, but is also a full line distributor of diagnostic systems and laboratory supplies to the physician office laboratory (POL) and other alternate care settings.  For additional information, please visit the company's website at www.labsco.com.


'/>"/>
SOURCE LABSCO
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LABSCO Strengthens Executive Leadership Team
2. LABSCO to Distribute Cepheid GeneXpert® Systems and Tests
3. Cepheid Appoints LABSCO as US Small Hospital Distributor
4. Sysmex America Signs Distributorship Agreement With LABSCO
5. Ignite Health Hires Brian Lefkowitz as Chief Creative Officer
6. UBM TechInsights Hires Medical Devices Industry Veteran Bill Betten
7. BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
8. Derycz Scientific Hires AstraZeneca Executive to Drive Global Sales Growth
9. Millstone Medical Outsourcing Expands Sales, Marketing Capacity, Hires Two Professionals
10. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
11. Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... , March 27, 2017 Invivotek, LLC, a ... in vivo pharmacology contract research organization (CRO), ... to its newly expanded preclinical research facility in ... provides a cleaner, renewable energy source to reduce costs ... Completion of the Genesis Solar Farm follows Invivotek,s recent ...
(Date:3/24/2017)... 2017  Zymo Research Corp., also known ... Inc., who designs, manufactures and distributes liquid ... teams Zymo Research,s DNA methylation detection and ... products with Hamilton,s high-throughput automation platforms. Zymo ... microbiomics and RNA isolation for use on ...
Breaking Medicine Technology:
(Date:3/27/2017)... London UK (PRWEB) , ... March 27, 2017 ... ... agility and ability to gain site attention and engagement over the household brands ... educational webinar will discuss how partnering with the right outsourcing payments ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO ... Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle ... Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... and conference coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, ... packaged with the April edition of American Veterinarian™. , “We look ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... Angeles, CA (PRWEB) , ... March 27, 2017 , ... ... men with prostate cancer, including all stages, is more than 95%. Once the cancer ... drastically to less than 30%. To find out how to avoid this latter group, ...
Breaking Medicine News(10 mins):